Benmoxin
Benmoxin
Benmoxin (pronunciation: ben-mox-in), also known as Neuralex, is a non-selective, irreversible and monoamine oxidase inhibitor (MAOI) that was used as an antidepressant in the 1960s before being discontinued due to safety concerns.
Etymology
The term "Benmoxin" is derived from its chemical name, Benzyl-morpholinyl-oxo-indole.
Pharmacology
Benmoxin works by inhibiting the action of a group of enzymes known as monoamine oxidase (MAO), which are involved in the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. By inhibiting these enzymes, Benmoxin increases the levels of these neurotransmitters, which can help to alleviate the symptoms of depression.
Related Terms
- Monoamine oxidase inhibitors (MAOIs): A class of drugs that includes Benmoxin and is used to treat depression.
- Serotonin: A neurotransmitter that is increased by Benmoxin and other MAOIs.
- Norepinephrine: Another neurotransmitter that is increased by Benmoxin and other MAOIs.
- Dopamine: A neurotransmitter that is also increased by Benmoxin and other MAOIs.
See Also
External links
- Medical encyclopedia article on Benmoxin
- Wikipedia's article - Benmoxin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski